198 related articles for article (PubMed ID: 23278180)
1. Interleukin-21 (IL-21) synergizes with IL-2 to enhance T-cell receptor-induced human T-cell proliferation and counteracts IL-2/transforming growth factor-β-induced regulatory T-cell development.
Battaglia A; Buzzonetti A; Baranello C; Fanelli M; Fossati M; Catzola V; Scambia G; Fattorossi A
Immunology; 2013 May; 139(1):109-20. PubMed ID: 23278180
[TBL] [Abstract][Full Text] [Related]
2. IL-2-deprivation and TGF-beta are two non-redundant suppressor mechanisms of CD4+CD25+ regulatory T cell which jointly restrain CD4+CD25- cell activation.
Wang G; Khattar M; Guo Z; Miyahara Y; Linkes SP; Sun Z; He X; Stepkowski SM; Chen W
Immunol Lett; 2010 Aug; 132(1-2):61-8. PubMed ID: 20570629
[TBL] [Abstract][Full Text] [Related]
3. IL-15 augments TCR-induced CD4+ T cell expansion in vitro by inhibiting the suppressive function of CD25 High CD4+ T cells.
Van Belle TL; Dooms H; Boonefaes T; Wei XQ; Leclercq G; Grooten J
PLoS One; 2012; 7(9):e45299. PubMed ID: 23028916
[TBL] [Abstract][Full Text] [Related]
4. 1α,25-dihydroxyvitamin D3 in combination with transforming growth factor-β increases the frequency of Foxp3⁺ regulatory T cells through preferential expansion and usage of interleukin-2.
Chambers ES; Suwannasaen D; Mann EH; Urry Z; Richards DF; Lertmemongkolchai G; Hawrylowicz CM
Immunology; 2014 Sep; 143(1):52-60. PubMed ID: 24673126
[TBL] [Abstract][Full Text] [Related]
5. Isolation and enrichment of mouse insulin-specific CD4
Đedović N; Paunović V; Stojanović I
J Immunol Methods; 2019 Jul; 470():46-54. PubMed ID: 31039339
[TBL] [Abstract][Full Text] [Related]
6. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of IL-4 reverses the nonresponsiveness of CD4+ T cells to regulatory T-cell induction in non-responder mouse strains.
Wang J; Han WG; Foks AC; Huizinga TW; Toes RE
Mol Immunol; 2010; 48(1-3):137-46. PubMed ID: 20869773
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region.
Rossetti M; Spreafico R; Saidin S; Chua C; Moshref M; Leong JY; Tan YK; Thumboo J; van Loosdregt J; Albani S
J Immunol; 2015 Jan; 194(1):113-24. PubMed ID: 25452562
[TBL] [Abstract][Full Text] [Related]
9. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
[TBL] [Abstract][Full Text] [Related]
10. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
[TBL] [Abstract][Full Text] [Related]
11. GARP-TGF-β complexes negatively regulate regulatory T cell development and maintenance of peripheral CD4+ T cells in vivo.
Zhou AX; Kozhaya L; Fujii H; Unutmaz D
J Immunol; 2013 May; 190(10):5057-64. PubMed ID: 23576681
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 facilitates the immune suppressor capacity of high-grade glioma-derived CD4 (+) CD25 (+) Foxp3 (+) T cells via releasing transforming growth factor beta.
Liang H; Yi L; Wang X; Zhou C; Xu L
Scand J Immunol; 2014 Aug; 80(2):144-50. PubMed ID: 24813240
[TBL] [Abstract][Full Text] [Related]
13. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.
Zheng SG; Wang JH; Gray JD; Soucier H; Horwitz DA
J Immunol; 2004 May; 172(9):5213-21. PubMed ID: 15100259
[TBL] [Abstract][Full Text] [Related]
14. Double-Edged Sword: Interleukin-2 Promotes T Regulatory Cell Differentiation but Also Expands Interleukin-13- and Interferon-γ-Producing CD8
Kato H; Perl A
Front Immunol; 2021; 12():635531. PubMed ID: 33763079
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells.
Gunnlaugsdottir B; Maggadottir SM; Ludviksson BR
Int Immunol; 2005 Jan; 17(1):35-44. PubMed ID: 15557315
[TBL] [Abstract][Full Text] [Related]
16. Acid Sphingomyelinase (ASM) is a Negative Regulator of Regulatory T Cell (Treg) Development.
Zhou Y; Salker MS; Walker B; Münzer P; Borst O; Gawaz M; Gulbins E; Singh Y; Lang F
Cell Physiol Biochem; 2016; 39(3):985-95. PubMed ID: 27512981
[TBL] [Abstract][Full Text] [Related]
17. Co-stimulation of T cell proliferation by transforming growth factor-beta 1.
Lee HM; Rich S
J Immunol; 1991 Aug; 147(4):1127-33. PubMed ID: 1831218
[TBL] [Abstract][Full Text] [Related]
18. IL-27 inhibits the development of regulatory T cells via STAT3.
Huber M; Steinwald V; Guralnik A; Brüstle A; Kleemann P; Rosenplänter C; Decker T; Lohoff M
Int Immunol; 2008 Feb; 20(2):223-34. PubMed ID: 18156621
[TBL] [Abstract][Full Text] [Related]
19. Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice.
Chen X; Priatel JJ; Chow MT; Teh HS
J Immunol; 2008 May; 180(9):5973-82. PubMed ID: 18424717
[TBL] [Abstract][Full Text] [Related]
20. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
